Short-term and long-term outcomes of 214 cases of non-immune hydrops fetalis

Kotaro Fukushima, Seiichi Morokuma, Yasuyuki Fujita, Kiyomi Tsukimori, Shoji Satoh, Masayuki Ochiai, Toshiro Hara, Tomoaki Taguchi, Norio Wake

研究成果: ジャーナルへの寄稿記事

34 引用 (Scopus)

抄録

Despite advances in diagnosis and management, non-immune hydrops fetalis (NIHF) has a high mortality rate. Perinatal survival depends on the underlying disorder and the gestational age at diagnosis. As prognostic information is limited, this study acquired data regarding the neurological development of perinatal survivors.We performed a retrospective chart review of 214 cases in which NIHF was diagnosed antenatally. We recorded maternal demographic characteristics and interventions and their effectiveness, as well as the short-term outcome (survival) and long-term outcome including developmental quotients. Among the affected fetuses, 91 (42.5%) survived the perinatal period. Fetuses with chylothorax, chyloascites, or meconium peritonitis, and those in whom therapy was effective, had high survival rates irrespective of the type of intrauterine intervention. The subsequent intact survival rate was 28/56 (50.0%), with intact defined as ratio of the number of infants with normal development to the number of all infants followed. In contrast to the perinatal survival rate, the intact survival rate decreased as gestational age at diagnosis advanced. These findings suggest that the long-term intact survival rate depends on the underlying cause of NIHF. Additionally, while survival was improved with intensive perinatal care during the perinatal period, aggressive perinatal intervention was not a prognostic factor for neurological outcome.

元の言語英語
ページ(範囲)571-575
ページ数5
ジャーナルEarly Human Development
87
発行部数8
DOI
出版物ステータス出版済み - 8 1 2011

Fingerprint

Hydrops Fetalis
Survival Rate
Gestational Age
Survival
Fetus
Perinatal Care
Chylothorax
Meconium
Critical Care
Peritonitis
Survivors
Mothers
Demography
Mortality

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynaecology

これを引用

Short-term and long-term outcomes of 214 cases of non-immune hydrops fetalis. / Fukushima, Kotaro; Morokuma, Seiichi; Fujita, Yasuyuki; Tsukimori, Kiyomi; Satoh, Shoji; Ochiai, Masayuki; Hara, Toshiro; Taguchi, Tomoaki; Wake, Norio.

:: Early Human Development, 巻 87, 番号 8, 01.08.2011, p. 571-575.

研究成果: ジャーナルへの寄稿記事

Fukushima, Kotaro ; Morokuma, Seiichi ; Fujita, Yasuyuki ; Tsukimori, Kiyomi ; Satoh, Shoji ; Ochiai, Masayuki ; Hara, Toshiro ; Taguchi, Tomoaki ; Wake, Norio. / Short-term and long-term outcomes of 214 cases of non-immune hydrops fetalis. :: Early Human Development. 2011 ; 巻 87, 番号 8. pp. 571-575.
@article{455f1899b7ff4f91a50b7360e2bdab0c,
title = "Short-term and long-term outcomes of 214 cases of non-immune hydrops fetalis",
abstract = "Despite advances in diagnosis and management, non-immune hydrops fetalis (NIHF) has a high mortality rate. Perinatal survival depends on the underlying disorder and the gestational age at diagnosis. As prognostic information is limited, this study acquired data regarding the neurological development of perinatal survivors.We performed a retrospective chart review of 214 cases in which NIHF was diagnosed antenatally. We recorded maternal demographic characteristics and interventions and their effectiveness, as well as the short-term outcome (survival) and long-term outcome including developmental quotients. Among the affected fetuses, 91 (42.5{\%}) survived the perinatal period. Fetuses with chylothorax, chyloascites, or meconium peritonitis, and those in whom therapy was effective, had high survival rates irrespective of the type of intrauterine intervention. The subsequent intact survival rate was 28/56 (50.0{\%}), with intact defined as ratio of the number of infants with normal development to the number of all infants followed. In contrast to the perinatal survival rate, the intact survival rate decreased as gestational age at diagnosis advanced. These findings suggest that the long-term intact survival rate depends on the underlying cause of NIHF. Additionally, while survival was improved with intensive perinatal care during the perinatal period, aggressive perinatal intervention was not a prognostic factor for neurological outcome.",
author = "Kotaro Fukushima and Seiichi Morokuma and Yasuyuki Fujita and Kiyomi Tsukimori and Shoji Satoh and Masayuki Ochiai and Toshiro Hara and Tomoaki Taguchi and Norio Wake",
year = "2011",
month = "8",
day = "1",
doi = "10.1016/j.earlhumdev.2011.04.015",
language = "English",
volume = "87",
pages = "571--575",
journal = "Early Human Development",
issn = "0378-3782",
publisher = "Elsevier Ireland Ltd",
number = "8",

}

TY - JOUR

T1 - Short-term and long-term outcomes of 214 cases of non-immune hydrops fetalis

AU - Fukushima, Kotaro

AU - Morokuma, Seiichi

AU - Fujita, Yasuyuki

AU - Tsukimori, Kiyomi

AU - Satoh, Shoji

AU - Ochiai, Masayuki

AU - Hara, Toshiro

AU - Taguchi, Tomoaki

AU - Wake, Norio

PY - 2011/8/1

Y1 - 2011/8/1

N2 - Despite advances in diagnosis and management, non-immune hydrops fetalis (NIHF) has a high mortality rate. Perinatal survival depends on the underlying disorder and the gestational age at diagnosis. As prognostic information is limited, this study acquired data regarding the neurological development of perinatal survivors.We performed a retrospective chart review of 214 cases in which NIHF was diagnosed antenatally. We recorded maternal demographic characteristics and interventions and their effectiveness, as well as the short-term outcome (survival) and long-term outcome including developmental quotients. Among the affected fetuses, 91 (42.5%) survived the perinatal period. Fetuses with chylothorax, chyloascites, or meconium peritonitis, and those in whom therapy was effective, had high survival rates irrespective of the type of intrauterine intervention. The subsequent intact survival rate was 28/56 (50.0%), with intact defined as ratio of the number of infants with normal development to the number of all infants followed. In contrast to the perinatal survival rate, the intact survival rate decreased as gestational age at diagnosis advanced. These findings suggest that the long-term intact survival rate depends on the underlying cause of NIHF. Additionally, while survival was improved with intensive perinatal care during the perinatal period, aggressive perinatal intervention was not a prognostic factor for neurological outcome.

AB - Despite advances in diagnosis and management, non-immune hydrops fetalis (NIHF) has a high mortality rate. Perinatal survival depends on the underlying disorder and the gestational age at diagnosis. As prognostic information is limited, this study acquired data regarding the neurological development of perinatal survivors.We performed a retrospective chart review of 214 cases in which NIHF was diagnosed antenatally. We recorded maternal demographic characteristics and interventions and their effectiveness, as well as the short-term outcome (survival) and long-term outcome including developmental quotients. Among the affected fetuses, 91 (42.5%) survived the perinatal period. Fetuses with chylothorax, chyloascites, or meconium peritonitis, and those in whom therapy was effective, had high survival rates irrespective of the type of intrauterine intervention. The subsequent intact survival rate was 28/56 (50.0%), with intact defined as ratio of the number of infants with normal development to the number of all infants followed. In contrast to the perinatal survival rate, the intact survival rate decreased as gestational age at diagnosis advanced. These findings suggest that the long-term intact survival rate depends on the underlying cause of NIHF. Additionally, while survival was improved with intensive perinatal care during the perinatal period, aggressive perinatal intervention was not a prognostic factor for neurological outcome.

UR - http://www.scopus.com/inward/record.url?scp=79960458261&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960458261&partnerID=8YFLogxK

U2 - 10.1016/j.earlhumdev.2011.04.015

DO - 10.1016/j.earlhumdev.2011.04.015

M3 - Article

C2 - 21592689

AN - SCOPUS:79960458261

VL - 87

SP - 571

EP - 575

JO - Early Human Development

JF - Early Human Development

SN - 0378-3782

IS - 8

ER -